Eagle Bay Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-248
| Closed | -$16.2K | – | 192 |
|
|
2024
Q4 | $16.2K | Sell |
248
-13
| -5% | -$852 | 0.01% | 490 |
|
|
2024
Q3 | $20.3K | Buy |
261
+12
| +5% | +$935 | 0.01% | 630 |
|
|
2024
Q2 | $19.4K | Buy |
249
+74
| +42% | +$5.77K | 0.01% | 444 |
|
|
2024
Q1 | $11.9K | Buy |
+175
| New | +$11.9K | 0.01% | 540 |
|
|
2023
Q2 | – | Sell |
-13
| Closed | -$902 | – | 846 |
|
|
2023
Q1 | $902 | Hold |
13
| – | – | ﹤0.01% | 823 |
|
|
2022
Q4 | $881 | Hold |
13
| – | – | ﹤0.01% | 821 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 796 |
|
|
2022
Q2 | $859 | Buy |
+13
| New | +$859 | ﹤0.01% | 873 |
|
|
2022
Q1 | – | Sell |
-26
| Closed | -$2K | – | 345 |
|
|
2021
Q4 | $2K | Sell |
26
-276
| -91% | -$21.2K | ﹤0.01% | 861 |
|
|
2021
Q3 | $19K | Buy |
+302
| New | +$19K | 0.01% | 596 |
|